Maroufi, Nazila Fathi <br/><br/>
The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.  [electronic resource] 

 -  Breast cancer (Tokyo, Japan)  Jul 2020 
 - 613-620 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1880-4233 
<br/><br/><label>Standard No.: </label>10.1007/s12282-020-01055-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Breast Neoplasms--drug therapy<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Survival--drug effects<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>NF-kappa B--metabolism<br/>Neoplasm Invasiveness--prevention & control<br/>Pyridines--pharmacology<br/>Spheroids, Cellular--drug effects